Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and ...
Research led by the Max Planck Institute for Biology of Aging in Cologne reports that misincorporation of ribonucleotides ...
The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy results for CUTX-101, demonstrating significant improvement in overall survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback